Marksans Pharma Limited — Updates, 02-06-2026: General Updates
02-06-2026 | 12:46 pm
02-06-2026 | 12:46 pm
Marksans Pharma launched a shareholder campaign to help claim unclaimed dividends from FY2018-19 onwards and update KYC details. This initiative aims to prevent fund transfers to a statutory body, ensuring investor empowerment.
No comments yet. Be the first to comment!
